trending Market Intelligence /marketintelligence/en/news-insights/trending/nihpnhou5rvaqhkx9pwc3q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Biohaven Pharmaceutical director resigns

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Biohaven Pharmaceutical director resigns

Biohaven Pharmaceutical Holding Co. Ltd. said Albert Cha notified the company of his intent to step down as the company's director, effective Sept. 7.

The company said Cha's resignation was not a result of any disagreement with the company or the board.

New Haven, Conn.-based Biohaven Pharmaceutical is a clinical-stage biopharmaceutical company that develops product candidates to treat neurological diseases, including rare disorders.